We have located links that may give you full text access.
Nuclear Factor-κB Clinical Significance in Breast Cancer: An Immunohistochemical Study.
Medical Principles and Practice : International Journal of the Kuwait University, Health Science Centre 2022 November 23
OBJECTIVES: Nuclear factor κB (NF-κB) is a superfamily of transcription factors that plays a key role in cancer genesis and progression. The present study aimed to explore the exact role of NF-κB/p65 as a marker in breast cancer and its relationship with other prognostic markers, such as tumour grade, tumour size, hormone receptors, and HER-2 expression.
METHODS: Ninety-nine unselected formalin-fixed paraffin-embedded invasive ductal and lobular tissue sections were evaluated by immunohistochemistry methods to measure NF-κB/p65 expression, ER, PR, HER-2 and Ki-67. The correlation between NF-κB/p65 and clinicopathological parameters was assessed.
RESULTS: NF-κB/p65 was only found in the cytoplasm and positively correlated with large tumours (≥2 cm) and high-grade tumours (P< 0.001 and P= 0.018, respectively). Other breast cancer markers, such as histological type (P= 0.766), HER-2 (P= 0.416), PR (P= 0.356), and ER (P= 0.606), had no significant link with NF-B/p65 expression. Furthermore, no significant relation with the Ki-67 marker was detected (P= 0.117).
CONCLUSION: The current study discovered a link between NF-κB/p65 overexpression and both large tumour size and higher grade. This might mean that the expression of NF-κB/p65 is associated with aggressive biological activity in breast cancer and that studying the mechanisms that lead to NF-κB/p65 cytoplasmic accumulation could lead to the discovery of novel therapeutic methods.
METHODS: Ninety-nine unselected formalin-fixed paraffin-embedded invasive ductal and lobular tissue sections were evaluated by immunohistochemistry methods to measure NF-κB/p65 expression, ER, PR, HER-2 and Ki-67. The correlation between NF-κB/p65 and clinicopathological parameters was assessed.
RESULTS: NF-κB/p65 was only found in the cytoplasm and positively correlated with large tumours (≥2 cm) and high-grade tumours (P< 0.001 and P= 0.018, respectively). Other breast cancer markers, such as histological type (P= 0.766), HER-2 (P= 0.416), PR (P= 0.356), and ER (P= 0.606), had no significant link with NF-B/p65 expression. Furthermore, no significant relation with the Ki-67 marker was detected (P= 0.117).
CONCLUSION: The current study discovered a link between NF-κB/p65 overexpression and both large tumour size and higher grade. This might mean that the expression of NF-κB/p65 is associated with aggressive biological activity in breast cancer and that studying the mechanisms that lead to NF-κB/p65 cytoplasmic accumulation could lead to the discovery of novel therapeutic methods.
Full text links
Trending Papers
A Personalized Approach to the Management of Congestion in Acute Heart Failure.Heart International 2023
Potential Mechanisms of the Protective Effects of the Cardiometabolic Drugs Type-2 Sodium-Glucose Transporter Inhibitors and Glucagon-like Peptide-1 Receptor Agonists in Heart Failure.International Journal of Molecular Sciences 2024 Februrary 21
Get seemless 1-tap access through your institution/university
For the best experience, use the Read mobile app
All material on this website is protected by copyright, Copyright © 1994-2024 by WebMD LLC.
This website also contains material copyrighted by 3rd parties.
By using this service, you agree to our terms of use and privacy policy.
Your Privacy Choices
You can now claim free CME credits for this literature searchClaim now
Get seemless 1-tap access through your institution/university
For the best experience, use the Read mobile app